ISSN: 2168-958X

Journal of Glycobiology

This article was originally published in a journal published by OMICS Publishing Group, and the attached copy is provided by

OMICS Publishing Group for the author’s benefit and for the benefit of the author’s institution, for commercial/research/educational use including without limitation use in instruction at your institution, sending it to specific colleagues that you know, and providing a copy to your institution’s administrator.

All other uses, reproduction and distribution, including without limitation commercial reprints, selling or licensing copies or access, or posting on open internet sites, your personal or institution’s website or repository, are requested to cite properly.

Available online at: OMICS Publishing Group (www.omicsonline.org)

Digital Object Identifier: http://dx.doi.org/10.4172/2168-958X.S1-001

The International Open AccessJournal of Glycobiology

Special Issue Title: Cancer Glycobioogy

Handling Editors

Giuseppina SimoneHealth Care University of Napoli, Italy

Shashikala R.InamdarKarnatak University Dharwad, Dharwad

GlycobiologyEligar et al., J Glycobiol 2013, S1

http://dx.doi.org/10.4172/2168-958X.S1-001

Research Article Open Access

J Glycobiology Cancer Glycobioogy ISSN: 2168-958X JGB, an open access journal

Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In VivoSachin M Eligar1, Radha Pujari2, Mohammed Azharuddin Savanur1, Nagaraj N Nagre1, Srikanth Barkeer1, Aravind Ingle3, Rajiv D Kalraiya3, Bale M Swamy1, Padma Shastry2 and Shashikala R Inamdar1*1Department of Studies in Biochemistry, Karnataka University, Dharwad-580 003, India2National Center for Cell Sciences, NCCS Complex, Ganeshkhind, Pune-411 007, India3Advanced Centre for Treatment, Research, and Education in Cancer, Kharghar, Navi Mumabi- 410 210, India

AbstractBackground: A lectin from the plant pathogenic fungus Rhizoctonia bataticola (RBL) has shown unique sugar-

binding specificity towards the complex N-glycans, which are known to be expressed in many cancers, including ovarian cancer. Previous studies have demonstrated that RBL exerts cytotoxic effects on human ovarian cancer PA-1 cells. In the present study, we determined the signaling mechanism of RBL-induced cytotoxicity in PA-1 cells upon binding to cell surface receptors and also assessed the anti-tumor activity of RBL in NOD-SCID mice bearing ovarian xenografts.

Methods: Cytotoxicity was determined by MTT assay, Cell cycle analysis, Annexin V staining, and expression of caspase-3 was determined by flow cytometry using specific fluorescent detection reagents. Western blotting was carried out to observe the intermediates of apoptotic pathway.

Results: Treatment of PA-1 cells with RBL decreased their viability in a dose- and time- dependent manner. Cell cycle analysis revealed an increase in the hypo diploid population in response to lectin treatment. RBL-treated cells stained with Annexin V and PI showed an increase in both the early and late apoptotic populations. The mechanism of RBL-induced apoptosis in PA-1 cells was assessed by the observed decrease in MMP (ΔΨm), release of cytochrome-c, activation of caspase-9 and -3, and cleavage of PARP. Specific pharmacological inhibitors revealed the involvement of caspase-9 and -3 but not caspase-8. RBL at a subtoxic concentration (50 μg/mouse) suppressed tumor growth in NOD-SCID mice bearing PA-1 xenografts.

Conclusions: The present study demonstrates that, RBL induced cytotoxicity in PA-1 cells is mediated by intrinsic apoptotic pathway. The present study strengthens the merit of RBL for its potential application in ovarian cancer research.

*Corresponding author: Dr. Shashikala R Inamdar, Professor, Department of Biochemistry, Karnataka University, Dharwad -580003 India, Tel: 0091-836-2771973, Fax: 0091-836-2747884; E-mail: pinkisri2001@yahoo.co.in

Received February 11, 2013; Accepted March 14, 2013; Published March 21, 2013

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Copyright: © 2013 Eligar SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Keywords: Rhizoctonia bataticola lectin; Growth inhibition; Apoptosis; PA-1 human ovarian cancer cells; Anti-tumor effect

IntroductionThe incidence of ovarian cancer, one of the leading causes of cancer

death among women worldwide, is increasing every year [1]. Most ovarian cancer cases are diagnosed at advanced stages when the cancer has already developed into a wide-spread disease [2]. Epithelial ovarian cancer makes up 80-90% of all ovarian malignancies [3]. Although there are many chemotherapeutic drugs that have shown high patient response rates after surgery, patients have a poor overall survival rate (25%); the survival rate decreases to 5% if patients are diagnosed at stage III or IV [4]. There is a great need for nontoxic, antitumor molecules in the treatment of many cancers, including ovarian cancer.

Lectins are a well-known group of multivalent carbohydrate-binding proteins that recognize specific glycans of cell surface receptors and mediate a variety of biological functions [5]. Recent studies on fungal lectins have attracted the attention of researchers due to their interesting biological properties and sugar specificities [6]. Various applications in cancer research are being developed for lectins that have specific affinity towards cancer-associated antigens and exhibit antitumor activity. As a result, some of these lectins are already currently used in clinical studies [7,8].

Recently, we reported the isolation of a mitogenic and immuno stimulatory lectin from the phyto pathogenic fungus Rizhoctonia bataticola (RBL) that exhibited complex sugar specificity. Glycan array analysis of RBL revealed its exclusive specificity towards N-glycans, primarily high mannose, tri- and tetra- antennary complex N-glycans, and tandem repeats of sialyl Lewis antigens. The various interactions of

RBL have been studied using human ovarian cancer cells PA-1, which are known to express these glycans. The results showed that RBL has cytotoxic effects on PA-1 cells, which can be effectively blocked by the addition of competing glycoproteins [9-11].

Malignant transformation is associated with a variety of glycosylation changes and is known to be involved in important events such as transformation, invasion, and metastasis [12]. One of the common glycosylation changes in cancer is the increased branching of N-glycans that express tri- and tetra-antennary oligosaccharides with terminal sialylation. The expression of sialyl Lewisa, sialyl Lewisx and their isomers on the N- and O-linked oligosaccharides is observed in various human malignancies that are involved in cancer progression. The expression of these altered glycans in breast, bladder, lung, ovary, and colon cancer correlates with poor prognosis [13]. Many protein tumor markers on epithelial ovarian cancer have been studied and are known to express altered cancer-associated glycans [14]. The ability

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Page 2 of 7

J Glycobiology Cancer Glycobioogy ISSN: 2168-958X JGB, an open access journal

of RBL to specifically recognize these altered glycans prompted us to study their interaction in ovarian cancer cells.

In the present study, we report the signaling mechanism involved in RBL-induced cell death in PA-1 cells in vitro and the anti-tumor effects of RBL in NOD-SCID mice with PA-1 xenografts in vivo.

MethodsReagents

Bovine serum albumin (BSA), bovine submaxillary mucin, fetuin, asialofetuin, phenyl methyl sulfonyl fluoride (PMSF), nonidet P-40 (NP-40), EDTA, 2-mercaptoethanol, Triton X-100, trypan blue, DAPI, Ribonuclease A, formaldehyde, Propidum iodide, Tetra methyl rhodamine ethylester (TMRE), and Digitonin were obtained from Sigma Chemical Co., St. Louis, MO, USA. Acrylamide, bis-acrylamide, Tris, sodium dodecyl sulphate (SDS), MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], and glycine were obtained from GE Life Sciences (Pittsburgh, PA, USA). Poly vinylene diflurodine (PVDF) membrane was obtained from Millipore (Bedford, MA, USA). Protease inhibitor cocktail was from Roche (Mannheim, Germany). Caspase inhibitors (z-VAD-fmk– pan-caspase inhibitor, z-IETD-fmk– a caspase-8 inhibitor, and z-LEHD-fmk– a caspase-9 inhibitor), mounting medium, Annexin-V detection kit, and Tissue culture grade plastic-wares were procured from BD Biosciences (San Jose, CA, USA). Antibodies against caspase-8 (Cat.#: 1007-1), active caspase-3 (Cat.#: 1476-1), and cytochrome-c (Cat.#: 3895-1) were from Epitomics (Burlingame, CA, USA). Caspase-9 (PA5-19904) and PARP (Cat.#: MA5-15031) antibodies were from Pierce (Rockford, IL, USA), and β-actin (Cat.#: 08691001) antibodies were from MP Biomedicals (Solon, OH, USA). Species-specific HRP-labeled secondary antibodies were procured from BioRad (Hercules, CA, USA). The active caspase-3 detection kit with FITC-DEVD-fmk was procured from Calbiochem (Billerica, MA, USA). All other chemicals used were of research grade.

The purification of RBL and the preparation of the FITC-labeled RBL were conducted according to methods described earlier [9].

Cell culture

The human ovarian cancer cell line PA-1 was procured from the American Type Culture Collection (ATCC, Rockville, MD, USA) and maintained in MEM (Gibco-Invitrogen, NY, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS), 1 mM glutamine, 1 mM sodium pyruvate, 100 mg/ml streptomycin, and 100 units/ml penicillin at 37°C in 5% CO2 and 95% humidified air. Exponentially growing PA-1 cells (80-85% confluent) were used for all the said studies.

Analysis of surface binding by confocal microscopy

PA-1 cells were grown on cover slips at 2×105cells/ml for 24 h before staining with FITC-RBL (2 µg/ml) for 1h at 4°C. Unbound lectin was washed with PBS, and cells were fixed with 2% para-formaldehyde and visualized using a confocal laser scanning microscope (Zeiss, Germany). DAPI was used as a nuclear stain.

Growth inhibitory studies

PA-1 cells at 5000 cells/well were grown in 96 well plates for 24 h. The dose- and time-dependent effects of RBL on PA-1 cells were determined by treating the cells with different concentrations (1.25 to 10 µg/ml) of RBL for 10 h or different time points (6 to 48 h) using 5 µg/ml of RBL. After each time point, cell viability was measured by the MTT assay as described earlier [9]. The percentage of viable cells was calculated compared to control treatments, which were considered

100% viable.

RBL-induced apoptosis in PA-1 cells

RBL-induced apoptosis was determined by cell cycle analysis. PA-1 cells at 2×105 cells/well in 6 well plate were grown for 24 h, then cells treated with RBL (5 µg/ml) for 3 and 6 h. Cells were harvested by gentle trypsinization and fixed in 70% chilled ethanol for 30 min at 4°C. Cells were treated with 50 μl Ribonuclease A (5 mg/ml) and stained with propidium iodide (50 μg/ml). The DNA content was analyzed by flow cytometry (FACS Calibur, BD, San Jose, CA, USA) to observe the distribution of cells in different phases of the cell cycle.

The induction of apoptosis by RBL was confirmed by dual staining with FITC-labeled Annexin V and propidium iodide. Briefly, PA-1 cells at 2×105 cells/well in 6 well plate were grown for 24 h and treated with RBL for 3 and 6 h. Cells were harvested by gentle trypsinization and resuspended in binding buffer at a concentration of 1×106 cells/ml, and stained with FITC-Annexin V and PI. The percentage of cells positive for Annexin V, PI, or both was determined by flow cytometry analysis.

Activation of caspase-3

PA-1 cells at 2×105 cells/well in 6 well plates were grown for 24 h and treated with RBL for 3 and 6 h. Cells were harvested by gentle trypsinization, and active caspase-3 was determined by using the caspase-3 detection kit (Calbiochem) according to the manufacturer’s instructions. The FITC-labeled caspase-3 inhibitor (FITC-DEVD-fmk) was used to detect active caspase -3 by flow cytometry analysis. Cells that were not treated with RBL were used as controls.

Role of caspases in RBL-induced cell death

PA-1 cells were pre-incubated with specific inhibitors against caspase-8 (z-IETD-fmk), caspase-9 (z-LEHD-fmk) or pan-caspase (z-VAD-fmk) at 40 µM for 1 h before treating with RBL (5 µg/ml) for 12h. Viable cells were measured by an MTT assay as described above.

Determining Mitochondrial Membrane Potential (ΔΨm)

PA-1 cells were grown on cover slips, treated with RBL (5 µg/ml) for 3 and 6 h, and stained with the mitochondrial-specific dye TMRE (200 nM) for 30 min. Cells were washed, fixed with 2% para-formaldehyde for 10 min, and visualized using a confocal laser scanning microscope. DAPI was used as a nuclear stain.

Western blot analysis

PA-1 cells were treated with RBL (5 µg/ml) for different time intervals up to 8 h. At specific time intervals, the cells were lysed using RIPA lysis buffer (120 mM NaCl, 1.0% Triton X-100, 20 mM Tris–HCl, pH 7.5, 100% glycerol, 2 mM EDTA, and protease inhibitor cocktail). In another experiment, cells were pre-incubated with pan caspase inhibitors (40 µM) for 1 h, treated with RBL (5 µg/ml) for 12 h, lysed, and prepared as mentioned above. Proteins were resolved by SDS-PAGE and transferred to a PVDF membrane. After blocking with 5% BSA, the blots were probed with primary antibodies for Caspase-8, -9, active caspase-3, and PARP followed by species-specific HRP-labeled secondary antibodies with appropriate dilutions as per the manufacturer’s instructions. The bands were visualized by enhanced chemiluminescence (Pierce, USA). Actin was used as a loading control.

Cytosolic proteins from RBL-treated and untreated cells were isolated by methods described by McCarthy et al. [15]. Cytosolic proteins were transblotted onto a PVDF membrane, probed with antibodies against cytochrome-c, and processed as mentioned above.

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Page 3 of 7

J Glycobiology Cancer Glycobioogy ISSN: 2168-958X JGB, an open access journal

In vivo antitumor activity in NOD-SCID miceInbred NOD-SCID mice were procured, maintained at the

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India on a synthetic diet, and used for the toxicity and anticancer studies with clearance from the ethics committee (IRB approval No.11/2009).

PA-1 cells (1×107) were injected subcutaneously into two NOD-SCID mice (donor mice). After 4 weeks, the tumors were excised from the donor mice and chopped into 2-3 mm sizes. Tumor pieces were transplanted subcutaneously into 18 NOD-SCID mice and maintained for 12 days to allow the tumor to grow to 5-6 mm. The mice were then divided randomly into three groups, with six animals in each group. Animals in Groups II & III were given intraperitoneal injections of RBL (25 and 50 µg/mice) every other day for 9 days. The animals in Group I were similarly injected with PBS as a negative control for 9 days. The animals were sacrificed after the 14th day and photographed. Tumor volume and weight were measured after excising the tumor, and mean tumor weight and volume were considered. Different parameters of toxicity, including total blood cell count, hemoglobin content, and serum liver enzyme levels (aspartate transaminase and alanine transaminase) were measured.

Statistical analysisEach experiment was performed at least three times, each time in

triplicate. The results were analyzed by one-way ANOVA followed by the ‘Newman-Keuls’ test for multiple comparisons using the ‘StatsDirect’ software. Data were considered significant when p<0.05.

ResultsSurface-binding and cytotoxicity of RBL in PA-1 cells

The localization of FITC-RBL on the cell surface was visualized by

confocal microscopy. Uniform binding of FITC-RBL was observed on the surface of PA-1 cells confirming its binding to cell surface (Figure 1A). The dose response profile of RBL-treated PA-1 cells revealed no significant growth inhibition at 1.25 and 2.50 µg/ml; however, at 5 and 10 µg/ml, significant cell death was observed (53 ± 4.68% and 56 ± 7.62%, respectively) (Figure 1B). Time kinetic studies revealed that cell death (53%) was observed as early as 6 h, and maximum cell death (89 ± 0.68%) was observed at 48 h (Figure 1C). These results suggest that RBL exhibits strong cytotoxicity in PA-1 cells at a 5 μg/ml dose in a time-dependent manner.

Induction of apoptosis by RBL

Treatment of PA-1 cells with RBL resulted in an increase of hypodiploid cells by 8.82% and 22.25% at 3 and 6 h, respectively, compared to 5.38% in the control sample. RBL treatment also decreased the S and G2/M phase cell population to 14.73% and 10.09% after 6 h, respectively, compared to 25.55% and 24.15% in the control group. An increase in the percentage of the G0/G1 population in RBL-treated cells (51.84 %) compared to untreated control cells (43.28%) was also observed after 6 h (Figure 2A).

RBL treatment of PA-1 cells resulted in a significant increase in the Annexin-V positive population (early apoptotic) by 4.54 and 23.30% after 3 and 6 h, respectively. The percentage of cells positive for both Annexin-V and PI (late apoptotic) increased to 46.71% compared to 0.42% in the control group, and a small population of cells (10%) positive for PI (necrosis) was also observed at the end of 6 h (Figure 2B).

Activation of caspases during RBL-induced apoptosis

RBL-treated PA-1 cells showed a 31.49 and 44.47% increase in the cells positive for active caspase-3 at 3 and 6 h, respectively, compared

A

BDAPI FITC-RBL Merged

20 µm 20 µm 20 µm

**

*

* ** *

* *

120

100

80

60

40

20

0

120

100

80

60

40

20

00 1.25 2.5 5 10 0 6 12 24 36 48

Viab

le c

ells

(%

)

Viab

le c

ells

(%

)

RBL (µg/mI) Time inh

* represents p < 0.05.

Figure 1: RBL binding and cytotoxic effects on PA-1 cells. (A) Human ovarian cancer PA-1 cells were stained with FITC-RBL and DAPI and then visualized by confocal microscopy. Images were captured at 63X magnification and show a uniform surface-binding of RBL. (B) PA-1 cells were incubated with RBL (1.25 to 10 µg/ml) for 10 h, and cell viability was measured by the MTT assay. (C) PA-1 cells were incubated with RBL (5 µg/ml) for different time points (6 to 48 h), and cell viability was measured after each time point by the MTT assay. The data are representative of three experiments performed in triplicate.

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Page 4 of 7

J Glycobiology Cancer Glycobioogy ISSN: 2168-958X JGB, an open access journal

to a 5.29% increase in untreated cells (Figure 3A). RBL-treated PA-1 cells showed a time-dependent increase in the activation of caspase-9 and -3 at 2, 4, and 8 h; in contrast, the expression of procaspase-8 remained constant at all time points, which suggests that caspase-8 is not involved in RBL-induced apoptosis. The increase in PARP cleavage was observed in time dependent manner (Figure 3B).

To demonstrate the involvement of caspases in RBL-induced apoptosis, cells were pre-incubated with pan-caspase inhibitors before receiving RBL treatment and PARP cleavage was determined by western blot analysis. In the presence of pan-caspase inhibitors, the cleavage of PARP was prevented, which suggests the involvement of caspases in RBL-induced apoptosis (Figure 3C).

The role of caspases in RBL-induced cell death was analyzed by using pharmacological inhibitors for specific caspases and a pan-caspase inhibitor. RBL-induced cell death was suppressed by 50 and 45% in the presence of caspase-9 and pan-caspase inhibitors, respectively; furthermore, there was no protection from apoptosis in cells pre-incubated with caspase-8 inhibitors (Figure 4A).

Loss of mitochondrial membrane potential and release of cytochrome-c

As RBL-induced apoptosis involves the activation of caspase-9, it was essential to analyze the breakdown of ΔΨm. The time-dependent loss of ΔΨm in RBL-treated PA-1 cells was visualized by confocal microscope. Untreated cells showed intact mitochondria with intense red staining that was visualized around the nucleus; meanwhile, RBL-

treated cells displayed a significant reduction in red staining and a diffused appearance of the mitochondria (Figure 4B).

The loss of ΔΨm typically involves the release of mitochondrial cytochrome-c to the cytosol, where it combines with apoptotic protease activating factor 1 (Apaf-1) and procaspase-9 to form the apoptosome, which results in the activation of caspase-9 and caspase-3. Consistent with these facts, a time-dependent increase in cytosolic cytochrome-c was observed (Figure 3B). Overall, these results suggest that RBL-induced apoptosis may be executed through the activation of mitochondrial-mediated intrinsic apoptotic pathway.

RBL induces antitumor effects in vivoThe growth inhibitory effect of RBL was also analyzed by in vivo

studies using NOD-SCID mice with PA-1 xenografts. A significant reduction in tumor size was observed in RBL-injected mice compared to control groups (Figure 5A). A reduction in average tumor volume and weight was observed in RBL-treated mice (50 µg/mice) after 9 days (Figure 5B). Tumor weight and volume reduced to 0.100 ± 0.012 g (P=0.029) and 193.5 ± 52 mm3 (P=0.0036) in RBL-treated mice in Group-III in contrast to control mice that had a tumor weight and volume of 0.319 ± 0.043 g and 618.0 ± 190 mm3, respectively. RBL-treated mice in Group-II also showed a partial reduction in tumor weight and volume (Figure 5C and D). Analysis of toxicity parameters in these mice showed no considerable difference in RBL-treated and untreated groups (Table 1).

DiscussionIn the present study, we evaluated the effect of an N-glycan-specific

A UNT 3 h 6 h

UNT 3 h 6 h

FL2-A FL2-A FL2-A

FL1-H FL1-H FL1-H

B

43.28

0.42 0.06

99.52

9.24

79.75

4.83

4.54

10.88 46.71

20.75 23.30

44.2551.84

10.09

22.25 14.73

20.54

24.298.8224.15

25.555.38

150

120

90

60

30

0

150

120

90

60

30

0

150

120

90

60

30

00 200 400 600 800 1000 0 200 400 600 800 1000 0 200 400 600 800 1000

Cou

nts

FL2-

H

M1 M1 M1M2 M2 M2

M3 M3 M3M4 M4 M4

100

101

102

1

03

104

100

1

01

102

1

03

104

100

1

01

102

1

03

104

100 101 102 103 104 100 101 102 103 104 100 101 102 103 104

Figure 2: RBL induces apoptosis in PA-1 cells. (A) Human ovarian cancer PA-1 cells were incubated with or without RBL (5 µg/ml) for 3 and 6 h. Cells were stained with PI and acquired on the FL2-A channel of the flow cytometer. M1, M2, M3, and M4 represent the subdiploid/apoptotic, G0/G1, S, and G2/M phases, respectively. (B) PA-1 cells were incubated with RBL as above, processed for Annexin V and PI staining, and analyzed by flow cytometry. The X-axis depicts Annexin V positive cells, and the Y axis depicts PI positive cells. The numbers indicate the number of viable, early apoptotic, late apoptotic, and necrotic cells that are present in the respective quadrants.

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Page 5 of 7

J Glycobiology Cancer Glycobioogy ISSN: 2168-958X JGB, an open access journal

A

C

B100

80

60

40

20

0100 101 102 103 104

UNT3 h6 h

FL1-H

Cytochrome-C(Cytosolic)

RBL

UNT RBL z-VAD z-VAD

PARPnative

β-Actin

116

43

1.5

1

0.5

0

2

1.5

1

0.5

0

0 2 4 8Time in h

Fold

cha

nge

Fold

cha

nge

Pro Caspase-8

Pro Caspase-9

Active caspase-3

PARP

β-Actin

0 2 4 8h kDa

55

46

17

14

116 89

43

Oh 2h 4h 8h

Caspase-8 Caspase-9 Caspase-3 Cytochrome-c PARP Native PARP Cleaved(cytosolic)

Figure 3: Involvement of caspases in RBL-induced apoptosis. (A) PA-1 cells were treated with RBL (5 μg/ml) for 3 and 6 h, and the activation of caspase-3 was determined by flow cytometry analysis using FITC-tagged caspase-3 inhibitors (FITC-DEVD-fmk). (B) Cells were treated with RBL (5 μg/ml) for 2, 4, and 8 h, and whole cell lysates were transblotted onto a membrane. The membrane was probed with antibodies for active caspase-3, -8, -9, cytochrome-c, and PARP. Actin was used as a loading control. (C) Cells were pre-incubated with pan-caspase inhibitors before RBL treatment for 12 h followed by western blot analysis for the detection of PARP cleavage. Actin was used as a loading control. The bar graphs depict fold change in the protein levels with respect to normalized actin levels.

* **

*

9876543210

Cel

l Via

bilit

y (fo

ld in

crea

se)

A B

UNT RBL

3 h

6 h

RBL

zVAD-FMK

zIETD-FMK

zLEHD

+ +

+

+ +

+

+

+

+

+

* represents p < 0.05. (B) The loss of MMP was visualized in PA-1 cells exposed to RBL (5 μg/ml) for 3 and 6 h by confocal microscopy. Mitochondria were stained red, and nuclei were stained blue using TMRE and DAPI, respectively.

Figure 4: Involvement of caspases in RBL induced cell death and Loss of MMP. (A) Cells were pre-incubated with specific caspase inhibitors before they were treated with RBL (5 μg/ml) for 12 h, and viable cells were measured by the MTT assay.

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Page 6 of 7

J Glycobiology Cancer Glycobioogy ISSN: 2168-958X JGB, an open access journal

lectin from Rizhoctonia bataticola on human ovarian cancer PA-1 cells both in vitro and in vivo. The study demonstrated that RBL induced strong cytotoxicity in PA-1 cells and that observed cell death is due to the activation of the intrinsic apoptotic pathway. RBL treatment showed significant tumor regression in ovarian cancer xenografts.

Cell surface expression of branched N-glycans, high mannose tri- and tetra-antennary, and bisecting N-glycans on glycoprotein is observed in many cancers, including ovarian cancer [13,16,17]. Some of these glycoproteins are considered to be cancer markers. Previously, we reported the cytotoxic effect of a mitogenic lectin RBL on PA-1 cells [9-10]. In the present study, the mechanism of RBL-induced cytotoxicity was studied in detail. RBL-induced PA-1 cell death was observed in a dose- and time-dependent manner. RBL induced apoptosis in PA-1 cells as determined by cell cycle analysis. RBL affected the cells in all phases of the cell cycle; specifically, RBL treatment decreased S and G2/M phase cell number and increased the G0/G1 and hypodipliod population. These results suggest that RBL may arrest cell growth at the G0/G1 phase of the cell cycle followed by the induction of apoptosis. RBL treatment increased the number of Annexin V-positive cells (70%)

along with an increase in the necrotic cell population (10%) after 6 h. This observation suggests that RBL is a potent inducer of apoptosis. Activation of caspase-9 and -3 was observed in a time-dependent manner, but there was no significant difference in the expression of procaspase-8 after RBL treatment. Further, caspase-9 and pan-caspase inhibitors, but not caspase-8 inhibitors, significantly prevented RBL-induced cell death, which suggests the lack of involvement of caspase-8 in RBL-induced apoptosis. A decrease in ΔΨm in RBL-treated PA-1 cells and the release of mitochondrial cytochrome-c were also observed. All these results support that RBL possibly induces apoptosis by activating the intrinsic apoptotic pathway.

Lectins from higher fungi have been shown to possess antiproliferative activity against different cancer cells in vitro and in vivo [8]. For many fungal lectins, the mechanism behind these apoptosis-inducing properties has not been studied in great detail. A lectin from Sclerotium rolfsii (SRL) has been shown to inhibit the growth of human ovarian (PA-1) and colon (HT29) cancer cells by inducing apoptosis through the activation of both the intrinsic and extrinsic apoptotic pathway [18,19]. Agrocybe aegerita lectin (AAL)

A B

C D

Control RBL 25 μg/mice RBL 50 μg/mice Control RBL 50 μg/mice

*

**

*

0.4

0.3

0.2

0.1

0Control 25 50

SRL (μg/mice) SRL (μg/mice)

Tum

or w

eigh

t (g)

Tum

or V

olum

e (m

m)

800

600

400

200

0Control 25 50

* represents p < 0.05.

Figure 5: RBL inhibits tumor growth in vivo. (A) NOD-SCID mice with PA-1 tumors were injected intraperitoneally with RBL (25, 50 µg/mice) or control PBS on alternate days for 9 days. Representative images of the animals after 14 days are shown. Tumors were excised (B), and tumor weight and volumes were compared between the groups (C and D).

RBL Control 25 µg/mice 50 µg/mice

Initial body weight (g) 23.46 23.26 23.36Final body weight(g) 23.76 23.66 23.35

Mortality None None NoneRBC (×106 /ccm) 6.77 6.99 6.81WBC (×103 /ccm) 2.86 2.71 2.86

Platelet count Lakhs/ccm 7.12 8.04 7.41Hemoglobin(g/dl) 8.95 9.3 8.98

AST(IU/L) 80.16 60.16 65.5ALT (IU/L) 20.16 18 23

NOD-SCID mice were injected intraperitoneally with RBL (25, and 50 µg/mouse) and TBS on alternate days for 9 days containing 6 animals in each treatment. The Average body weight, total blood cell count, and biochemical parameters in serum were determined on 14th day and represented.

Table 1: RBL toxicity in mice.

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Page 7 of 7

J Glycobiology Cancer Glycobioogy ISSN: 2168-958X JGB, an open access journal

had demonstrated inhibition of cell growth in many cancer cells, and its apoptosis-inducing property has been studied in detail in HeLa cells [20]. The majority of plant lectins are known to induce apoptosis by arresting cell growth at the G0/G1 phase and activating both the extrinsic and intrinsic apoptotic pathways [21]. Unlike the previously reported fungal lectins, RBL is potent because of its ability to induce apoptosis at low concentrations and at early time points by activating the intrinsic apoptotic pathway.

RBL suppressed tumor size and volume up to 70% in ovarian cancer xenografts, and RBL-treated mice were healthy without any signs of toxicity. Mushroom lectins from Pleurotus citrinopileatus and Russula lepida have shown antitumor activity in vivo in mice bearing Sarcoma 180 (S-180) [22,23]. A lectin from Pleurotus ostreatus has been shown to induce antitumor effects in mice bearing S-180 and mouse hepatoma H-22 cells [24]. The antitumoral effect of RBL is observed at a much lower concentration and more rapid time frame than the earlier-reported fungal lectins. These preliminary in vivo studies with RBL need to be further investigated before it is exploited for clinical applications.

In conclusion RBL induced potent toxicity in ovarian cancer PA-1 cells in vitro. The inhibition of growth can be attributed to its induction of apoptosis involving the mitochondrial-mediated intrinsic apoptotic pathway. RBL also suppressed tumor growth in vivo in an ovarian cancer xenograft model. The present study demonstrates the possible potential use of RBL in ovarian cancer therapeutics and warrants further investigation.

Acknowledgements

SME is senior research fellow under the UGC Meritorious fellowship. The work is supported by funding from the Department of Biotechnology, India under the IPLS program and UGC- sponsored CPEPA and UPE program.

Conflict of Interest

The author declares no conflict of interest.

References

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90

2. van Dalen A, Favier J, Burges A, Hasholzner U, de Bruijn HW, et al. (2000) Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients. Gynecol Oncol 79: 444-450

3. Riman T, Persson I, Nilsson S (1998) Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) 49: 695-707

4. Gupta D, Lis CG (2009) Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature. J Ovarian Res 2:13

5. Sharon N, Lis H (2004) History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 14: 53-62

6. Konska G (2006) Lectins of higher fungi (Macromycetes)-their occurrence, physiological role, and biological activity. Int J Med Mushr 8:19-30.

7. Liu B, Bian HJ, Bao JK (2010) Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett 287: 1-12

8. Khan F, Khan MI (2011) Fungal lectins: Current molecular and biochemical perspectives. Int J Biol Chem 5:1-20.

9. Nagre NN, Chachadi VB, Sundaram PM, Naik RS, Pujari R, et al. (2010) A potent mitogenic lectin from the mycelia of a phytopathogenic fungus, Rhizoctonia bataticola, with complex sugar specificity and cytotoxic effect on human ovarian cancer cells. Glycoconj J 27: 375-386

10. Pujari R, Nagre NN, Chachadi VB, Inamdar SR, Swamy BM, et al. (2010) Rhizoctonia bataticola lectin (RBL) induces mitogenesis and cytokine production in human PBMC via p38 MAPK and STAT-5 signaling pathways. Biochim Biophys Acta 1800: 1268-1275

11. Pujari R, Eligar SM, Kumar N, Nagre NN, Inamdar SR, et al. (2012) CD45-mediated signaling pathway is involved in Rhizoctonia bataticola lectin (RBL)-induced proliferation and Th1/Th2 cytokine secretion in human PBMC. Biochem Biophys Res Commun 419: 708-714

12. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA (2001) Glycosylation and the immune system. Science 291: 2370-2376

13. Ghazarian H, Idoni B, Oppenheimer SB (2011) A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem 113: 236-247

14. Meyer T, Rustin GJ (2000) Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer 82 : 1535-1538

15. McCarthy FM, Cooksey AM, Burgess SC (2009) Sequential detergent extraction prior to mass spectrometry analysis. Methods Mol Biol 528:110-118

16. Machado E, Kandzia S, Carilho R, Altevogt P, Conradt HS, et al. (2011) N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. Glycobiology 21: 376-386

17. Abbott KL, Nairn AV, Hall EM, Horton MB, McDonald JF, et al. (2008) Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics 8: 3210-3220

18. Eligar SM, Pujari R, Swamy BM, Shastry P, Inamdar SR (2012) Sclerotium rolfsii lectin inhibits proliferation and induces apoptosis in human ovarian cancer cell line PA-1. Cell Prolif 45: 397-403

19. Inamdar SR, Savanur MA, Eligar SM, Chachadi VB, Nagre NN, et al. (2012) The TF-antigen binding lectin from Sclerotium rolfsii inhibits growth of human colon cancer cells by inducing apoptosis in vitro and suppresses tumour growth in vivo. Glycobiology 22: 1227-1235

20. Liang Y, Lin JC, Wang K, Chen YJ, Liu HH, et al. (2010) A nuclear ligand MRG15 involved in the proapoptotic activity of medicinal fungal galectin AAL (Agrocybe aegerita lectin). Biochim Biophys Acta 1800: 474-480

21. Lam SK, Ng TB (2011) Lectins: production and practical applications. Appl Microbiol Biotechnol 89: 45-55

22. Li YR, Liu QH, Wang HX, Ng TB (2008) A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus. Biochim Biophys Acta 1780: 51-57

23. Zhang G, Sun J, Wang H, Ng TB (2010) First isolation and characterization of a novel lectin with potent antitumor activity from a Russula mushroom. Phytomedicine 17: 775-781

24. Wang H, Gao J, Ng TB (2000) A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem Biophys Res Commun 275: 810-816

Submit your next manuscript and get advantages of OMICS Group submissionsUnique features:

• Userfriendly/feasiblewebsite-translationofyourpaperto50world’sleadinglanguages• AudioVersionofpublishedpaper• Digitalarticlestoshareandexplore

Special features:

• 250OpenAccessJournals• 20,000editorialteam• 21daysrapidreviewprocess• Qualityandquickeditorial,reviewandpublicationprocessing• IndexingatPubMed(partial),Scopus,EBSCO,IndexCopernicusandGoogleScholaretc• SharingOption:SocialNetworkingEnabled• Authors,ReviewersandEditorsrewardedwithonlineScientificCredits• Betterdiscountforyoursubsequentarticles

Submityourmanuscriptat:http://www.omicsonline.org/submission/

Citation: Eligar SM, Pujari R, Savanur MA, Nagre NN, Barkeer S, et al. (2013) Rhizoctonia Bataticola Lectin (RBL) Induces Apoptosis in Human Ovarian Cancer PA-1 Cells and Suppresses Tumor Growth In Vivo. J Glycobiol S1: 001. doi:10.4172/2168-958X.S1-001

Thisarticlewasoriginallypublishedinaspecialissue,Cancer GlycobioogyhandledbyEditor(s).Prof.GiuseppinaSimone,HealthCareUniversityofNapoli,Italy;ShashikalaR.Inamdar,KarnatakUniversityDharwad,India